Erenumab for episodic migraine prophylaxis
Sign Up to like & getrecommendations! Published in 2019 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2019.1565996
Abstract: ABSTRACT Introduction: This paper reviews placebo-controlled randomized double-blind studies with erenumab for the prevention of migraine. Erenumab is a fully human monoclonal antibody (mAb), which specifically blocks the calcitonin gene-related peptide (GGRP) receptor. Areas covered:… read more here.
Keywords: episodic migraine; migraine; erenumab episodic; migraine prophylaxis ... See more keywords